Abbott announced U.S. availability of Lingo, the company’s first continuous glucose monitoring system available without a prescription. The Lingo system includes a biosensor and a mobile app designed for consumers who want to improve their overall health and wellness. Lingo is based on Abbott’s world-leading FreeStyle Libre continuous glucose monitoring technology, now used by more than 6 million people with diabetes globally.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABT:
Questions or Comments about the article? Write to editor@tipranks.com